- Home
- » Tags
- » Deramciclane
Top View
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- (12) Patent Application Publication (10) Pub. No.: US 2004/0120895 A1 Dugger, III (43) Pub
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Sahab Uddin JIDDT
- Deramciclane | Medchemexpress
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Effects of 5-HT2 Receptor Ligands on Tail Pinch-Induced Stress Responding and Open Field Behavior" (2005)
- Opportunities and Challenges of Psychiatric Drug Discovery: Roles for Scientists in Academic, Industry, and Government Settings
- Wo 2007/044693 A2
- Efficacy of Drug Treatments for Generalised Anxiety Disorder: Systematic Review and Meta-Analysis
- (12) Patent Application Publication (10) Pub. No.: US 2014/0038949 A1 Schultz Et Al
- Human Neurogenesis Assay: Ramelteon
- 5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
- (12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
- In Vitro–In Vivo Correlations Based on in Vitro Dissolution of Parent Drug Diltiazem and Pharmacokinetics of Its Metabolite
- Neurogenesis Via Modulation of the Muscarinic Receptors
- Neurological Disease
- The Concise Guide to PHARMACOLOGY 2015/16: Transporters
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- A61p25/06 (2006.01) A61p25/22 (2006.01)
- Occupancy of Dopamine D3 and D2 Receptors by Buspirone: a &Lsqb;11C&Rsqb;-(&Plus;)-PHNO PET Study in Humans
- Pharmaceutical Appendix to the Tariff Schedule 2
- Sleep Apnea and CMV Driver Safety
- PRACTICE GUIDELINE for the PHARMACOLOGICAL TREATMENT of ANXIETY DISORDERS in the ELDERLY Chittaranjan Andrade1, Saifuddin Kharawala2
- Pharmaceuticals Appendix
- GI Angol Phd Thesis E 1
- Diagnosis & Treatment
- Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
- Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care
- Anxiety Disorder Does Pharmacology Improve Outcome?
- Further Characterization of the Glyt-1 Inhibitor Org25935: Anti-Alcohol, Neurobehavioral And… Possible Outcome of Org25935-Treatment